Why INJ faltered above $17.50 despite Injective’s breakthroughs

4 months ago 1

ARTICLE AD BOX

The launch of the BUIDL index highlights Injective's capabilities in the decentralized finance and asset tokenization niches.

1. Homepage
2. Crypto
3. Why INJ faltered above $17.50 despite Injective’s breakthroughs